Concurrent administration of farnesol protects acetaminophen‐induced acute hepatic necrosis in mice

Abstract Acetaminophen (APAP) is known to cause acute liver injury and acute liver failure in Western countries. This study investigates the protective role of farnesol (FAR) (C 15 H 26 O), a natural sesquiterpene alcohol in essential oils, against APAP‐induced acute liver necrosis in mice. Mice were injected with a single dose of APAP (300 mg/kg) via an intraperitoneal route. Different groups of mice were concurrently treated with a single dose of FAR 25 mg/kg, FAR 50 mg/kg, and N ‐acetylcysteine. APAP administration caused a significant increase in transaminase activities and malondialdehyde (MDA) levels in the serum and liver tissue, respectively, with a concomitant decrease in intracellular antioxidants, including reduced glutathione (GSH) in the liver tissue. APAP intoxication upregulated proinflammatory cytokines such as tumor necrosis factor‐α, interleukin‐1β (IL‐1β), IL‐6, nuclear factor‐κB (NF‐κB), and IκB kinase β in the liver tissue. FAR and N ‐acetylcysteine (NAC) administrations concurrently with APAP prevented serum transaminase increase in serum and MDA levels in the liver tissue. A high dose of FAR and NAC treatments significantly inhibited GSH and other antioxidant depletion. FAR and NAC treatments also downregulated the expression of proinflammatory markers. FAR treatments protects against APAP‐induced acute liver injury and offers antioxidant and anti‐inflammatory effects by inhibiting the NF‐κB pathway involved in the transcription of genes responsible for inflammatory cytokine synthesis.